Idera to Present at the Cowen & Co. 34th Annual Health Care Conference

[Business Wire] – Idera Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that Company man more

View todays social media effects on IDRA

View the latest stocks trending across Twitter. Click to view dashboard

See who Idera is hiring next, click here to view